Clinical Trial: A prospective, multicenter, randomized controlled study on the combination regimen of reduced-dose versus standard-dose dexamethasone in the treatment of newly diagnosed multiple myeloma (China)

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized controlled study on the combination regimen of reduced-dose versus standard-dose dexamethasone in the treatment of newly diagnosed multiple myeloma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132070

Registration Time: 2026/09/09

Type: Interventional study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=277293

Published by HT Digital Content Services with permission from Health Daily Digest....